Chicago Equity Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$9.73M |
| 2 |
Johnson Controls International
JCI
|
+$8.19M |
| 3 |
PACW
PacWest Bancorp
PACW
|
+$6.74M |
| 4 |
West Pharmaceutical
WST
|
+$6.55M |
| 5 |
Take-Two Interactive
TTWO
|
+$6.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
M&T Bank
MTB
|
+$11.4M |
| 2 |
CADE
Cadence Bancorporation
CADE
|
+$10.8M |
| 3 |
Amazon
AMZN
|
+$9.65M |
| 4 |
Mastercard
MA
|
+$7.92M |
| 5 |
Apple
AAPL
|
+$7.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.87% |
| 2 | Technology | 15.41% |
| 3 | Industrials | 12.67% |
| 4 | Healthcare | 12.29% |
| 5 | Consumer Discretionary | 11.36% |
Similar funds
Chicago Equity Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Chicago Equity Partners held 1,034 positions worth $2.1B, down 6.4% from $2.25B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Chicago Equity Partners withdrew a net $151M in Q3 2019, closing 187 positions and reducing 400 holdings. Its most notable exit was Cadence Bancorporation, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
Against the trend, Chicago Equity Partners opened a new position in West Pharmaceutical worth $6.74M.
- Chicago Equity Partners's largest Q3 2019 buy was West Pharmaceutical: 47,545 shares worth $6.74M.
- Chicago Equity Partners added most to Citigroup in Q3 2019, an estimated $9.73M increase.
- Chicago Equity Partners's biggest Q3 2019 reduction was M&T Bank, cutting an estimated $11.4M.
- Chicago Equity Partners fully exited Cadence Bancorporation in Q3 2019, selling an estimated $10.8M.
- Chicago Equity Partners's ten largest holdings make up 11% of its $2.1B portfolio in Q3 2019.
- Chicago Equity Partners opened 154 new positions and closed 187 in Q3 2019.
- Chicago Equity Partners's portfolio value fell 6.4% quarter-over-quarter to $2.1B.
Based on Chicago Equity Partners's 13F filing for Q3 2019, filed 30 Oct 2019.